Carle Ryckman
About Carle Ryckman
Carle Ryckman is the Disease Area Head (Director of Medical Affairs), Oncology at Bristol Myers Squibb in Montréal, Québec, Canada, with extensive experience in medical affairs and immunology.
Current Role at Bristol Myers Squibb
Carle Ryckman serves as the Disease Area Head (Director of Medical Affairs) in Oncology at Bristol Myers Squibb in Montréal, Québec, Canada. In this role, Ryckman leads the development and execution of strategic product support plans for the oncology portfolio. He oversees non-registrational post-marketing studies and investigator-sponsored trials, ensuring alignment with both global and local medical and clinical development strategies.
Previous Experience at Valeant Pharmaceuticals
From 2013 to 2018, Carle Ryckman worked at Valeant Pharmaceuticals as the Director of Medical Affairs for the Pharma BU in Laval, Quebec. During his five-year tenure, he was responsible for overseeing medical affairs strategies and ensuring that all activities were compliant with regulatory standards and aligned with business objectives.
Early Career at Bristol Myers Squibb
Carle Ryckman has an extensive history with Bristol Myers Squibb, having held various roles before his current position. In 2013, he briefly served as the Disease Strategic Lead for the Intercontinental Region in Global Immunoscience. Prior to that, Ryckman was the Medical Lead in Immunology from 2012 to 2013 and a Scientific Advisor in Immunology from 2010 to 2012. These positions were all based in Montréal, Québec.
Experience at Bayer and Servier Canada
Before joining Bristol Myers Squibb, Carle Ryckman gained valuable experience at Bayer and Servier Canada. From 2005 to 2008, he was part of the Medical Affairs team at Bayer. In 2009, he worked as a Medical Science Liaison at Servier Canada for 11 months, further broadening his experience in the pharmaceutical industry.
Education and Expertise
Carle Ryckman achieved his Ph.D. in Immunology from Université Laval, where he studied from 2001 to 2004. His academic background laid the foundation for his expertise in immunology and oncology, which he has applied throughout his professional career.